3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
18
Breast Neoplasms
17
Advanced Solid Tumors
16
Advanced Solid Tumor
12
Carcinoma, Non-Small-Cell Lung
10
Myelodysplastic Syndromes
8
Solid Tumor
6
Recurrence
6
Prostatic Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
6
Uterine Cervical Neoplasms
5
Triple Negative Breast Neoplasms
5
Stomach Neoplasms
5
Ovarian Neoplasms
5
Carcinoma, Hepatocellular
5
Small Cell Lung Carcinoma
4
Myeloproliferative Disorders
4
Multiple Myeloma
4
Advanced Solid Tumour
4
Advanced Malignant Solid Tumor
4
Solid Tumors
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Leukemia, Myelomonocytic, Chronic
3
Biliary Tract Neoplasms
3
Advanced Lung Cancer
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Interventions
Etoposide
4
Cisplatin
4
lutetium Lu 177 dotatate
2
fludarabine phosphate
2
fludarabine
2
Cyclophosphamide
2
Bleomycin
2
repotrectinib
1
pegfilgrastim
1
etoposide phosphate
1
copper dotatate CU-64
1
Watchful Waiting
1
Vorinostat
1
Teniposide
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Respiratory Physiological Phenomena
1
Practice Guidelines as Topic
1
Platinum
1
Nivolumab
1
Mesna
1
Magnetic Resonance Spectroscopy
1
Lutetium-177
1
Lutetium
1
Injections
1
Immunotherapy
1
Filgrastim
1
Drug Therapy
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms, Germ Cell and Embryonal
×
Injections
×
Clear all
NCT02582697
2025-06-15
P3BEP
University of Sydney
Phase 3
Recruiting
500 enrolled